nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—embryo—polycystic ovary syndrome	0.0651	0.208	CbGeAlD
Tyloxapol—LPL—Triacylglyceride Synthesis—PNPLA2—polycystic ovary syndrome	0.0612	0.089	CbGpPWpGaD
Tyloxapol—LPL—adrenal cortex—polycystic ovary syndrome	0.0533	0.171	CbGeAlD
Tyloxapol—LPL—Fatty Acid Beta Oxidation—PNPLA2—polycystic ovary syndrome	0.0463	0.0673	CbGpPWpGaD
Tyloxapol—LPL—pituitary gland—polycystic ovary syndrome	0.0431	0.138	CbGeAlD
Tyloxapol—LPL—adipose tissue—polycystic ovary syndrome	0.0429	0.137	CbGeAlD
Tyloxapol—LPL—adrenal gland—polycystic ovary syndrome	0.0385	0.123	CbGeAlD
Tyloxapol—LPL—female gonad—polycystic ovary syndrome	0.0359	0.115	CbGeAlD
Tyloxapol—LPL—endocrine gland—polycystic ovary syndrome	0.0334	0.107	CbGeAlD
Tyloxapol—LPL—Retinoid metabolism and transport—AKR1C1—polycystic ovary syndrome	0.0265	0.0385	CbGpPWpGaD
Tyloxapol—LPL—Retinoid metabolism and transport—RBP4—polycystic ovary syndrome	0.0244	0.0354	CbGpPWpGaD
Tyloxapol—LPL—Vitamin A and Carotenoid Metabolism—RBP4—polycystic ovary syndrome	0.0234	0.0341	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—LIFR—polycystic ovary syndrome	0.0222	0.0323	CbGpPWpGaD
Tyloxapol—LPL—Retinoid metabolism and transport—AKR1C3—polycystic ovary syndrome	0.0204	0.0296	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—RETN—polycystic ovary syndrome	0.0181	0.0263	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—LIF—polycystic ovary syndrome	0.0181	0.0263	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—RBP4—polycystic ovary syndrome	0.0161	0.0234	CbGpPWpGaD
Tyloxapol—LPL—Diseases associated with visual transduction—AKR1C1—polycystic ovary syndrome	0.0135	0.0196	CbGpPWpGaD
Tyloxapol—LPL—Diseases associated with visual transduction—RBP4—polycystic ovary syndrome	0.0124	0.0181	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.0117	0.017	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—polycystic ovary syndrome	0.0108	0.0157	CbGpPWpGaD
Tyloxapol—LPL—Diseases associated with visual transduction—AKR1C3—polycystic ovary syndrome	0.0104	0.0151	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—SLC2A4—polycystic ovary syndrome	0.0102	0.0148	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—NAMPT—polycystic ovary syndrome	0.00868	0.0126	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—LMNA—polycystic ovary syndrome	0.00823	0.012	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—NCOR1—polycystic ovary syndrome	0.00815	0.0119	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CDH15—polycystic ovary syndrome	0.00764	0.0111	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00734	0.0107	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—ADIPOQ—polycystic ovary syndrome	0.0071	0.0103	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—LEP—polycystic ovary syndrome	0.00671	0.00975	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—SLC2A4—polycystic ovary syndrome	0.00671	0.00975	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—PPARG—polycystic ovary syndrome	0.00638	0.00927	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—INS—polycystic ovary syndrome	0.00626	0.0091	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00623	0.00906	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—PPARG—polycystic ovary syndrome	0.00584	0.00849	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.0058	0.00844	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.0058	0.00844	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.00547	0.00795	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—NCOR1—polycystic ovary syndrome	0.00536	0.0078	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—NR3C1—polycystic ovary syndrome	0.00496	0.00721	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00486	0.00707	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00461	0.0067	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—IRS2—polycystic ovary syndrome	0.00451	0.00655	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—LEP—polycystic ovary syndrome	0.00441	0.00641	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.0044	0.00639	CbGpPWpGaD
Tyloxapol—LPL—Disease—NMNAT3—polycystic ovary syndrome	0.00427	0.0062	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00394	0.00573	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00394	0.00573	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—IRS1—polycystic ovary syndrome	0.00394	0.00572	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—PPARG—polycystic ovary syndrome	0.00384	0.00559	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—INS—polycystic ovary syndrome	0.00377	0.00548	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00374	0.00544	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—IGF1—polycystic ovary syndrome	0.00365	0.0053	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NMNAT3—polycystic ovary syndrome	0.00357	0.0052	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—SERPINE1—polycystic ovary syndrome	0.00346	0.00503	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00341	0.00496	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00333	0.00484	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—LPCAT2—polycystic ovary syndrome	0.00327	0.00475	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SUOX—polycystic ovary syndrome	0.00327	0.00475	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00323	0.00469	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ISYNA1—polycystic ovary syndrome	0.00304	0.00442	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00297	0.00432	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00277	0.00403	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00273	0.00397	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00263	0.00383	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AKR1C2—polycystic ovary syndrome	0.00258	0.00376	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—TEAD2—polycystic ovary syndrome	0.00258	0.00376	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00248	0.00361	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—DLG4—polycystic ovary syndrome	0.00246	0.00358	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00245	0.00356	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00244	0.00355	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NPB—polycystic ovary syndrome	0.00239	0.00347	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00231	0.00335	CbGpPWpGaD
Tyloxapol—LPL—Disease—RPL37A—polycystic ovary syndrome	0.0022	0.0032	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PNPLA2—polycystic ovary syndrome	0.00217	0.00315	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00216	0.00314	CbGpPWpGaD
Tyloxapol—LPL—Disease—HMMR—polycystic ovary syndrome	0.00208	0.00303	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SRD5A1—polycystic ovary syndrome	0.00205	0.00298	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00199	0.0029	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00199	0.0029	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—STAR—polycystic ovary syndrome	0.00196	0.00285	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00194	0.00281	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00187	0.00271	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NCOR1—polycystic ovary syndrome	0.00184	0.00268	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00181	0.00263	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00176	0.00256	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HMMR—polycystic ovary syndrome	0.00175	0.00254	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00172	0.0025	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKR1C1—polycystic ovary syndrome	0.00172	0.0025	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HSD3B1—polycystic ovary syndrome	0.00167	0.00242	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—IL6—polycystic ovary syndrome	0.00165	0.00239	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00165	0.00239	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.0016	0.00233	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGF18—polycystic ovary syndrome	0.00159	0.00232	CbGpPWpGaD
Tyloxapol—LPL—Disease—RBP4—polycystic ovary syndrome	0.00158	0.0023	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00156	0.00227	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—LHB—polycystic ovary syndrome	0.00152	0.00221	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—LEP—polycystic ovary syndrome	0.00152	0.0022	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HSD3B2—polycystic ovary syndrome	0.00148	0.00216	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00146	0.00212	CbGpPWpGaD
Tyloxapol—LPL—Disease—GAB1—polycystic ovary syndrome	0.00145	0.00211	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AKR1C1—polycystic ovary syndrome	0.00144	0.00209	CbGpPWpGaD
Tyloxapol—LPL—Disease—NAMPT—polycystic ovary syndrome	0.00142	0.00206	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00137	0.00199	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00133	0.00194	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SULT2A1—polycystic ovary syndrome	0.00132	0.00192	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKR1C3—polycystic ovary syndrome	0.00132	0.00192	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PPARG—polycystic ovary syndrome	0.00132	0.00192	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FST—polycystic ovary syndrome	0.0013	0.00189	CbGpPWpGaD
Tyloxapol—LPL—Disease—TNRC6B—polycystic ovary syndrome	0.0013	0.00189	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—INS—polycystic ovary syndrome	0.0013	0.00188	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00128	0.00187	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—RRM2—polycystic ovary syndrome	0.00128	0.00186	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—LHB—polycystic ovary syndrome	0.00127	0.00185	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—AKT2—polycystic ovary syndrome	0.00125	0.00182	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00124	0.0018	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—YAP1—polycystic ovary syndrome	0.00123	0.0018	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.0012	0.00175	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SCT—polycystic ovary syndrome	0.00119	0.00173	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NAMPT—polycystic ovary syndrome	0.00119	0.00172	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.00118	0.00171	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP11A1—polycystic ovary syndrome	0.00117	0.0017	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.00116	0.00169	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00114	0.00165	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00112	0.00162	CbGpPWpGaD
Tyloxapol—LPL—Disease—TCF7L2—polycystic ovary syndrome	0.00111	0.00162	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AKR1C3—polycystic ovary syndrome	0.00111	0.00161	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00111	0.00161	CbGpPWpGaD
Tyloxapol—LPL—Disease—SLC2A4—polycystic ovary syndrome	0.00109	0.00159	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP17A1—polycystic ovary syndrome	0.00109	0.00158	CbGpPWpGaD
Tyloxapol—LPL—Disease—PRL—polycystic ovary syndrome	0.00104	0.00152	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00103	0.0015	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00102	0.00148	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—INSR—polycystic ovary syndrome	0.000974	0.00142	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—TH—polycystic ovary syndrome	0.000943	0.00137	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000925	0.00135	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC2A4—polycystic ovary syndrome	0.000917	0.00133	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000911	0.00132	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PGR—polycystic ovary syndrome	0.000902	0.00131	CbGpPWpGaD
Tyloxapol—LPL—Disease—NCOR1—polycystic ovary syndrome	0.000875	0.00127	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP19A1—polycystic ovary syndrome	0.000862	0.00125	CbGpPWpGaD
Tyloxapol—LPL—Disease—NRG1—polycystic ovary syndrome	0.000859	0.00125	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000838	0.00122	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000838	0.00122	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000818	0.00119	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ATF1—polycystic ovary syndrome	0.0008	0.00116	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00078	0.00113	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTHFR—polycystic ovary syndrome	0.000774	0.00112	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GNAS—polycystic ovary syndrome	0.000769	0.00112	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000738	0.00107	CbGpPWpGaD
Tyloxapol—LPL—Disease—IRS2—polycystic ovary syndrome	0.000736	0.00107	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NCOR1—polycystic ovary syndrome	0.000733	0.00107	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRL—polycystic ovary syndrome	0.000731	0.00106	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP1A1—polycystic ovary syndrome	0.000695	0.00101	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000694	0.00101	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MTHFR—polycystic ovary syndrome	0.000648	0.000942	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000643	0.000935	CbGpPWpGaD
Tyloxapol—LPL—Disease—IRS1—polycystic ovary syndrome	0.000642	0.000934	CbGpPWpGaD
Tyloxapol—LPL—Disease—INS—polycystic ovary syndrome	0.000615	0.000894	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000613	0.000891	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000602	0.000875	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKT2—polycystic ovary syndrome	0.000595	0.000864	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—IL6—polycystic ovary syndrome	0.000566	0.000823	CbGpPWpGaD
Tyloxapol—LPL—Disease—SERPINE1—polycystic ovary syndrome	0.000565	0.000822	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPARG—polycystic ovary syndrome	0.000525	0.000764	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—POMC—polycystic ovary syndrome	0.000518	0.000753	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000515	0.000749	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—INS—polycystic ovary syndrome	0.000515	0.000749	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—LEP—polycystic ovary syndrome	0.000504	0.000733	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IRS1—polycystic ovary syndrome	0.00045	0.000654	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—POMC—polycystic ovary syndrome	0.000433	0.00063	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—INS—polycystic ovary syndrome	0.000431	0.000626	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000417	0.000606	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000416	0.000605	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000396	0.000575	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000272	0.000396	CbGpPWpGaD
Tyloxapol—LPL—Disease—IL6—polycystic ovary syndrome	0.000269	0.000391	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL6—polycystic ovary syndrome	0.000188	0.000274	CbGpPWpGaD
